Andy has worked as a strategy consultant in health and life sciences for over 25 years. His work spans all areas of Research & Development and he is a recognised thought leader in drug development, patient engagement, pharma services, regulatory and pharmacovigilance operations.
Andy also chairs Lucid Group and Optibrium, is a Non-Executive Director at Datapharm Ltd and is Professor of Practice at King’s College London.
Previously Andy trained as a Surgeon, was a Consultant at Accenture, and co-founded and led Kinapse Ltd (now part of Syneos Health).
Andy lives in the UK and is an enthusiastic, albeit wayward, golfer.